Latest News

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance has initiated a pivotal clinical trial, SimpliciTB, that will evaluate whether a new four-drug regimen can treat most types of tuberculosis including multidrug-resistant TB more quickly and effectively than currently-available treatments.

Source link




Related posts

Physical Binding Improves Tumor Targeting Nanoparticles

Newsemia

Medical News Today: Could acid reflux explain sudden unexpected death in epilepsy?

Newsemia

September News in Brief

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy